TORTUS vs ArteraAI
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
TORTUS compared with ArteraAI
| Detail | 
TORTUS | 
ArteraAI |
|---|
| What it does | Clinical AI partner to NHS systems for safe, regulated ambient voice documentation
| Personalized precision medicine powered by AI for cancer therapy
|
|---|
| Stage | Not given
| Not given
|
|---|
| Founded | 2022
| Not given
|
|---|
| Based in | GB
| US
|
|---|
| Pricing model | Not given
| Contact for pricing
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - Speaker-diarised audio capture with local encryption
- Automated clinical note generation in seconds
- Clinical code suggestion with SNOMED CT
- EHR integration with automatic write-back
- Hallucination detection and removal via The Shell
- Consultation transcript with full recording history
- Custom template creation for specialities
- Context box for information not spoken aloud
- 48+ clinical specialties supported including emergency, outpatients, mental health, and physiotherapy
- Integrated into major NHS EHR systems and phone platforms
| - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
|
|---|
| What makes it different | - First and only ambient voice technology certified as UKCA Class IIa medical device
- Proprietary hallucination detection system removes 92.7% of unsupported statements
- Independently proven 13.4% productivity gain in Emergency Departments across NHS trials
- Patient audio never stored, clinician-approved write-back to records
| - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 46 ▲ +1 (up) since last check | 57 ● no change since last check |
|---|
| Trust Flow (Majestic) | 14 | 15 |
|---|
| Citation Flow (Majestic) | 28 | 27 |
|---|
| Referring domains (Majestic) | 252 | 285 |
|---|
4 details filled in for both companies.
More alternatives to TORTUS More alternatives to ArteraAI